Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Leonardo Fleury, Orlandini"'
Autor:
Maria Fernanda Imperio Pereira, Isabela Panzeri Carlotti Buzatto, Hélio Humberto Angotti Carrara, Fabiana de Oliveira Buono, Jurandyr Moreira de Andrade, Leonardo Fleury Orlandini, Daniel Guimarães Tiezzi
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 46 (2024)
Abstract Objective Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with triple-negative breast cancer (TNBC) with tumors > 1 cm or positive axillary nodes. Pathologic complete response (pCR) has been used as an endpoint t
Externí odkaz:
https://doaj.org/article/b7bab846bd754a598a08a535b74a4e5a
Autor:
Leonardo Fleury Orlandini, Maria Vitória do Nascimento Antonio, Claiver Renato Espreafico Jr, Priscila Longhin Bosquesi, Omero Benedito Poli-Neto, Jurandyr Moreira de Andrade, Francisco José Cândido dos Reis, Daniel Guimarães Tiezzi
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 81-88 (2021)
PURPOSEBreast cancer screening is not recommended for young women (< 40 years old); therefore, those diagnosed are more likely to have advanced and metastatic disease, reducing treatment outcomes. This study aimed to investigate breast cancer epidemi
Externí odkaz:
https://doaj.org/article/0e4add5a7e594de18d1ac3a5a9b839b6
Autor:
Leonardo Fleury Orlandini, Francisco José Cândido dos Reis, Willian Abraham da Silveira, Marcelo Guimarães Tiezzi, Jurandyr Moreira de Andrade, Alfredo Ribeiro-Silva, Ryan Deaton, Maarten Bosland, Daniel Guimarães Tiezzi
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 40, Iss 12, Pp 779-786 (2018)
Abstract Objective The use of molecular markers can identify a subgroup of tumors with distinct recurrence patterns. The present study aimed to characterize the immunohistochemical expression of vimentin (VIM), of E-cadherin (CDH1), and of cytokerati
Externí odkaz:
https://doaj.org/article/38d3be9d43154038861271cac7463314
Autor:
Daniel Guimarães Tiezzi, Leonardo Fleury Orlandini, Hélio Humberto Angotti Carrara, Francisco José Cândido dos Reis, Jurandyr Moreira de Andrade
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 41, Iss 11, Pp 633-635 (2019)
Externí odkaz:
https://doaj.org/article/84d5b1b42a0443e6ac4adcab8e28f831
Autor:
Isabela Campeti, Cuoghi, Mariana Furlani, da Silva Soares, Gustavo Motta Cabello, Dos Santos, Francisco José Candido, Dos-Reis, Omero Benedicto, Poli-Neto, Jurandyr Moreira, de Andrade, Priscila Longhin, Bosquesi, Leonardo Fleury, Orlandini, Daniel Guimarães, Tiezzi
Publikováno v:
Journal of Global Health. 12
Mammographic screening has been used to reduce breast cancer mortality worldwide and remains the main modality for the early detection of this disease. Women from low- and middle-income countries still lack access to periodic mammograms and efficient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b7991a26a1d2e6483937515c4b79340
https://doi.org/10.7189/jogh.12.04061
https://doi.org/10.7189/jogh.12.04061
Autor:
Leonardo Fleury Orlandini, Francisco Jc dos Reis, Jurandyr Moreira de Andrade, Franklin F Pimentel, Daniel Guimarães Tiezzi, Hélio Ha Carrara
Publikováno v:
Cancer Research. 80:P2-08
Background: Despite of several studies described body mass index (BMI) as a poor prognostic factor in breast cancer (BC) patients, the available data are still conflicting and the relation between obesity and BC remains unclear. In this study we eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ac4c48e63aa45616e15ff4e8f702765
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-31
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-31
Autor:
Leonardo Fleury Orlandini, Francisco J.C. dos Reis, Franklin F Pimentel, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, Hélio Ha Carrara
Publikováno v:
Cancer Research. 80:P2-08
Background: About 20% of breast cancer (BC) subtypes are classified as HER2-positive (HER2+), recognized as a biomarker for worse prognosis. Trastuzumab (T) is a monoclonal antibody approved to treat HER2+ early BC since 2006 and included in the Worl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb29a5f6d49f540fb35507f4c3030150
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-22
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-22
Autor:
Leonardo Fleury Orlandini
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Obesidade tem sido associada a um aumento de risco para desenvolvimento de câncer de mama, além de maior recorrência e mortalidade por esta neoplasia. Alguns biomarcadores séricos associados a inflamação sistêmica, por serem de baixo custo e f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0923cbe9446c03946783108995b292af
Autor:
Leonardo Fleury Orlandini, Franklin Fernandes Pimentel, Jurandyr Moreira de Andrade, Francisco José Cândido dos Reis, Leticia De Mattos- Arruda, Daniel Guimarães Tiezzi
Publikováno v:
Mastology.
Objectives: We aimed to explore the association of a readily available biomarker of systemic inflammation, the neutrophil-to-lymphocyte ratio (NLR), with breast cancer survival. Methodology: We undertook a single-centered retrospective study of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::820e115df9319f1bebe9bd84a6f1eaff
https://doi.org/10.29289/259453942021v31s2038
https://doi.org/10.29289/259453942021v31s2038
Autor:
Leonardo Fleury Orlandini, F. J. Candido dos Reis, Hélio Ha Carrara, Carlos Caldas, Daniel Guimarães Tiezzi, Oscar M. Rueda, Jurandyr Moreira de Andrade, L. de Mattos
Publikováno v:
Annals of Oncology. 31:S54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::936cb6cab9e469d1b97df7a76bd5e686
https://doi.org/10.1016/j.annonc.2020.03.216
https://doi.org/10.1016/j.annonc.2020.03.216